Fig. 1

General trend observed in lab values of COVID-19 patients prior to and post tocilizumab therapy and thrombotic events (not based on exact patient values)

General trend observed in lab values of COVID-19 patients prior to and post tocilizumab therapy and thrombotic events (not based on exact patient values)